Non-24-hour sleep-wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder.

Published in: Neuropsychopharmacology reports (2020)

N24SWD is a disease that seriously impairs social life and productivity. We propose a possible treatment strategy for N24SWD using ramelteon and suvorexant.

Keyphrases

autism spectrum disorder
healthcare
blood pressure
mental health
climate change
intellectual disability
depressive symptoms
smoking cessation